Nu Skin Enterprises, Inc. (NUS) stock
NUSNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/3069% below fair value
$3.78−0.15 (-3.82%)
Close on Nov 17, 2026Market cap $184.00MP/E –Yield –
Nu Skin Enterprises total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Nu Skin Enterprises's total debt was $203.73M at Sep 30, 2026. For fiscal 2025 it was $224.19M, down 43.0% from the year before. Over ten years it grew -1.1% a year on average. The highest annual figure on record is $503.04M in fiscal 2023.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $224.19M | -43.0% |
| FY2024 | Dec 31, 2024 | $393.61M | -21.8% |
| FY2023 | Dec 31, 2023 | $503.04M | +25.0% |
| FY2022 | Dec 31, 2022 | $402.47M | +7.0% |
| FY2021 | Dec 31, 2021 | $376.28M | +12.2% |
| FY2020 | Dec 31, 2020 | $335.39M | -7.3% |
| FY2019 | Dec 31, 2019 | $361.96M | -15.9% |
| FY2018 | Dec 31, 2018 | $430.46M | +10.8% |
| FY2017 | Dec 31, 2017 | $388.63M | -6.8% |
| FY2016 | Dec 31, 2016 | $416.89M | +67.0% |
| FY2015 | Dec 31, 2015 | $249.59M | +0.9% |
| FY2014 | Dec 31, 2014 | $247.34M | +36.1% |
| FY2013 | Dec 31, 2013 | $181.68M | -6.3% |
| FY2012 | Dec 31, 2012 | $193.98M | +42.1% |
| FY2011 | Dec 31, 2011 | $136.55M | -15.1% |
| FY2010 | Dec 31, 2010 | $160.88M | +2.8% |
| FY2009 | Dec 31, 2009 | $156.52M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $203.73M | -11.1% |
| Q2 FY2026 | Jun 30, 2026 | $213.66M | -14.2% |
| Q1 FY2026 | Mar 31, 2026 | $223.59M | -6.4% |
| Q4 FY2025 | Dec 31, 2025 | $224.19M | -43.0% |
| Q3 FY2025 | Sep 30, 2025 | $229.04M | -47.2% |
| Q2 FY2025 | Jun 30, 2025 | $248.90M | -45.7% |
| Q1 FY2025 | Mar 31, 2025 | $238.76M | -50.6% |
| Q4 FY2024 | Dec 31, 2024 | $393.61M | -21.8% |
| Q3 FY2024 | Sep 30, 2024 | $433.47M | -13.8% |
| Q2 FY2024 | Jun 30, 2024 | $458.33M | -9.7% |
| Q1 FY2024 | Mar 31, 2024 | $483.18M | +15.0% |
| Q4 FY2023 | Dec 31, 2023 | $503.04M | +25.0% |
| Q3 FY2023 | Sep 30, 2023 | $502.90M | +18.4% |
| Q2 FY2023 | Jun 30, 2023 | $507.75M | +18.9% |
| Q1 FY2023 | Mar 31, 2023 | $420.11M | +13.9% |
| Q4 FY2022 | Dec 31, 2022 | $402.47M | +7.0% |
| Q3 FY2022 | Sep 30, 2022 | $424.82M | +9.3% |
| Q2 FY2022 | Jun 30, 2022 | $427.18M | -3.1% |
| Q1 FY2022 | Mar 31, 2022 | $369.00M | -4.9% |
| Q4 FY2021 | Dec 31, 2021 | $376.28M | +12.2% |
| Q3 FY2021 | Sep 30, 2021 | $388.56M | +13.4% |
| Q2 FY2021 | Jun 30, 2021 | $440.84M | +6.2% |
| Q1 FY2021 | Mar 31, 2021 | $388.12M | -8.1% |
| Q4 FY2020 | Dec 31, 2020 | $335.39M | -7.3% |
| Q3 FY2020 | Sep 30, 2020 | $342.66M | -6.6% |
| Q2 FY2020 | Jun 30, 2020 | $414.93M | +1.6% |
| Q1 FY2020 | Mar 31, 2020 | $422.20M | +5.2% |
| Q4 FY2019 | Dec 31, 2019 | $361.96M | -15.9% |
| Q3 FY2019 | Sep 30, 2019 | $366.72M | -18.2% |
| Q2 FY2019 | Jun 30, 2019 | $408.49M | -12.7% |
| Q1 FY2019 | Mar 31, 2019 | $401.25M | -14.6% |
| Q4 FY2018 | Dec 31, 2018 | $430.46M | +10.8% |
| Q3 FY2018 | Sep 30, 2018 | $448.22M | +7.2% |
| Q2 FY2018 | Jun 30, 2018 | $468.01M | +10.2% |
| Q1 FY2018 | Mar 31, 2018 | $469.93M | +9.7% |
| Q4 FY2017 | Dec 31, 2017 | $388.63M | -6.8% |
| Q3 FY2017 | Sep 30, 2017 | $418.22M | – |
| Q2 FY2017 | Jun 30, 2017 | $424.59M | – |
| Q1 FY2017 | Mar 31, 2017 | $428.48M | – |
| Q4 FY2016 | Dec 31, 2016 | $416.89M | – |
See a number that looks wrong?